Michael Settecase, DO
Family Medicine · Olympia Fields, ILNPI 1447368055
Payments from drug & device makers
Across 294 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- Pfizer$687
- AstraZeneca$366
- Amgen$326
- Johnson & Johnson$305
- Novo Nordisk$254
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,20699%
- Education$371%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 81 | $1,475 |
| Pfizer | 44 | $687 |
| AstraZeneca | 16 | $366 |
| Amgen | 20 | $326 |
| Johnson & Johnson | 19 | $305 |
| Novo Nordisk | 16 | $254 |
| Novartis | 13 | $236 |
| Exact Sciences | 11 | $223 |
| Astellas Pharma US Inc | 9 | $153 |
| Merck | 9 | $144 |
| Boehringer Ingelheim | 7 | $135 |
| GSK | 7 | $134 |
| AbbVie(2 entities) | 5 | $106 |
| Bayer | 4 | $82 |
| E.r. Squibb & Sons, L.L.C. | 3 | $68 |
| Phathom Pharmaceuticals, Inc. | 4 | $68 |
| Zyla Life Sciences, Inc. | 3 | $57 |
| Kowa Pharmaceuticals America, Inc. | 3 | $42 |
| Sunovion Pharmaceuticals Inc. | 3 | $41 |
| Sanofi Pasteur Inc. | 2 | $37 |
| Amarin Pharma, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $30 |
| Corcept Therapeutics | 1 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Dexcom, Inc. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Dynavax Technologies Corporation | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Biogen | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Melinta Therapeutics, LLC | 1 | $14 |
How this compares
$5,244 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 414 | $200,293 |
| JanuviaSitagliptin Phosphate | 122 | $81,992 |
| JardianceEmpagliflozin | 110 | $74,103 |
| XareltoRivaroxaban | 99 | $55,195 |
| TrulicityDulaglutide | 22 | $42,175 |
| OzempicSemaglutide | 34 | $38,697 |
| EntrestoSacubitril/Valsartan | 52 | $32,858 |
| MounjaroTirzepatide | 26 | $31,678 |
| Breo ElliptaFluticasone/Vilanterol | 56 | $29,827 |
| RybelsusSemaglutide | 16 | $23,180 |
| TradjentaLinagliptin | 21 | $17,691 |
| XifaxanRifaximin | 21 | $16,642 |
| XanaxAlprazolam | 12 | $14,688 |
| MyrbetriqMirabegron | 30 | $14,222 |
| LinzessLinaclotide | 14 | $14,095 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $687 | $200,293414 claims |
| Boehringer IngelheimJardiance, Tradjenta | $135 | $91,794131 claims |
| MerckJanuvia | $144 | $81,992122 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $1,475 | $73,85248 claims |
| Novo NordiskOzempic, Rybelsus | $254 | $61,87750 claims |
| GSKBreo Ellipta, Anoro Ellipta, Trelegy Ellipta, Incruse Ellipta | $134 | $59,58997 claims |
| Johnson & JohnsonXarelto | $305 | $55,19599 claims |
| NovartisEntresto | $236 | $32,85852 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $27 | $16,64221 claims |
| Astellas Pharma US IncMyrbetriq | $153 | $14,22230 claims |
| AbbVieLinzess | $106 | $14,09514 claims |
| AstraZenecaSymbicort | $366 | $6,35123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Olympia Fields
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.